Genmab — November 2020
-
Dit estimat lyder godt:-)
-
enmab
@Genmab
·
6 min
#ICMYI: Last week, we launched our website in Japan. Hear more from our CEO Jan van de Winkel on how we are expanding our presence in Japan with a goal to transform cancer treatment. http://genmab.co.jp -
Onsdag kan vi udregne % satsen, når Genmab har aflagt regnskab...
-
Tak-079 frontline MM completion udskudt et års tid https://www.clinicaltrials.gov/ct2/history/NCT03984097?A=10&B=11&C=Side-by-Side#StudyPageTop
-
Tak for updateringer Solsen
-
God morgen. :-
-
Asien: Store stigninger mens investorer afventer præsidentvalg
//www.proinvestor.com/investornyt/669224/asien-store-stigninger-mens-investorer-afventer-praesidentvalg -
God morgen
-
Nordea hæver fair value på Genmab til 2071 fra 1936, rating hold.
-
Peak sale estimate på Tepezza hæves til USD 4bn fra 3-3.5bn
-
Peak sale estimate på Kesimpta hæves til USD 3-3.5bn fra 2.5bn
-
Nordea siger Tepezza royalty procentsats er 6,5%
-
DnB Markets
Rune Majlund DahlGenmab
- Good Q3 growth in key products
In their Q3 reports, JnJ and Horizon noted higher Darzalex and Tepezza sales, respectively, than we and consensus expected. We have updated our Q3e sales accordingly, and are now c14% above consensus, supporting our view that the 2020 guidance should be narrowed towards the high end. We reiterate our HOLD and DKK2,352 target price.
- Good Q3 growth in key products
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind